From the Editor - BioPharm International

ADVERTISEMENT

From the Editor
  • What We Don't Know May, In Fact, Hurt Us



    Now is a good time for companies to know their suppliers well.

    What the Heparin Crisis Should Tell Us


    The cause of the heparin crisis is still unknown. We do know, however, that the FDA is severely underfunded.

    Inspections in a Global Industry



    In our increasingly global industry; foreign manufacturing inspections are more important than ever.

    It's the Intangibles that Matter


    The number one source of job satisfaction? A sense of accomplishment from a job well done.

    Taking a Closer Look


    Many companies acknowledged that Western regulatory standards are tougher than those in China.

    The Difficulty of Giving Things Up


    The challenge is not in coming up with a list of activities to discard, but in finding a feasible way to stop doing them.

    What Comes Next


    Today, product costs, not process science, cause the most concern.

    From the Editor: Issues of Scale


    In analyzing the industry's current challenges, let's be careful before extrapolating about what they mean.

    From the Editor: After Zheng


    The corruption of China's food and drug sectors is not limited to one man. Likewise, real reform will require the efforts of many.

ADVERTISEMENT

ADVERTISEMENT

Advertiser Gallery
Click here